Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
CA 2262415 A1 · Owner: Riley, Lee W. · Inventors: Chong, Pele; Riley, Lee W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a DNA molecule conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages. Peptides, proteins, or polypeptides (e.g. the Mycobacterium cell entry protein or Mcep) encoded by this gene fragment are useful in vaccines to prevent infection by Mycobacterium tuberculosis while the antibodies raised , against these peptides proteins, or polypeptides can be employed in passively immunizing those already infected by the organism. These proteins peptides, polypeptides, and antibodies may be utilized in diagnostic assays to detect Mycobacterium tuberculosis in tissue or bodily fluids. The peptides proteins, or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 6, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 6, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 6, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.